Aurobindo Pharma Ltd
Aurobindo Pharma's GHG Emissions Data Preview
In 2023, Aurobindo Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Aurobindo Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Aurobindo Pharma's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Aurobindo Pharma amounted to 941,471 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Aurobindo Pharma increased by 9.62%, suggesting that the company faced challenges in reducing its emissions from its core operations.
Aurobindo Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Aurobindo Pharma's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Aurobindo Pharma were 447,207 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Aurobindo Pharma reduced its Scope 1 emissions over time?
Since 2019, Aurobindo Pharma's Scope 1 emissions have increased by 9.19%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Aurobindo Pharma's Scope 1 emissions increased by 23.67%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
What are Aurobindo Pharma's Scope 2 emissions?
In 2023, Aurobindo Pharma reported Scope 2 greenhouse gas (GHG) emissions of 494,264 tCOâ‚‚e without specifying the calculation method.
Has Aurobindo Pharma reduced its Scope 2 emissions over time?
Since 2019, Aurobindo Pharma's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Aurobindo Pharma 's emissions have plateaued with no significant change in its energy consumption footprint.
Compared to the previous year (2022), Aurobindo Pharma's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Aurobindo Pharma 's emissions have plateaued with no significant change in its energy consumption footprint.
What methodology does Aurobindo Pharma use for Scope 2 reporting?
In 2023, Aurobindo Pharma reported its Scope 2 emissions using an unspecified methodology.
Aurobindo Pharma's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)